# AADC Gene Therapy for Parkinson's Disease

> **NCT02418598** · PHASE1,PHASE2 · TERMINATED · sponsor: **Jichi Medical University** · enrollment: 2 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **GENETIC:** Cohort1
- **GENETIC:** Cohort2

## Key facts

- **NCT ID:** NCT02418598
- **Lead sponsor:** Jichi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04-14
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-03-31
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** another clinical study for regulatory approval is planned
- **Last updated:** 2019-08-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02418598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02418598, "AADC Gene Therapy for Parkinson's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02418598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*